The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

SGLT2 inhibitors and dulaglutide are associated with comparable risk for dementia; however, it is uncertain whether these findings generalize to newer GLP-1 RAs.

The acetaminophen cysteine adduct assay slightly improves the accuracy in diagnosing between acetaminophen hepatoxicity and ischemic hepatic injury.

IVF vs natural conception was associated with a higher risk for severe maternal morbidity, even among low-risk patients without comorbidities.

Policy interventions to mitigate heat-related illness are needed based on the relationship between high HVI and severe stroke.

The incidence of a composite cardiovascular disease (CVD) end point is increased among older adults with cancer, especially those with metastatic, hematological, and lung cancer.

SGLT-2 inhibitors were associated with the lowest risk for incidental dementia relative to DPP-4 inhibitors and GLP-1RAs in type 2 diabetes.

Patients undergoing peritoneal dialysis (PD) have significantly higher thyroxine (T4) concentrations than hemodialysis (HD) patients and higher free T4 (FT4) concentrations at 12 and 24 months.